Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc. to December 16, 2019

    NEXT STORY
    Genomics Market to Exhibit a Stellar CAGR of 18.7%, Demand for Genomic Products to Augment Owing to Increasing Number of Product Launches: Fortune Business Insights
    PREV STORY
    Changes in the Board of Directors and the Corporate Executive Committee of Roche
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    BeiGene Announces Clinical and Non-Clinical Data on BRUKINSA™ (Zanubrutinib) and Tislelizumab to Be Presented at the 25th European Hematology Association (EHA) Virtual Congress

    author_avatar
    NASDAQ Market News

    EDAP Records First Three U.S. Orders for Ablatherm HIFU

    LYON, France, Nov. 12, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global ...

    author_avatar
    NASDAQ Market News

    Reata Pharmaceuticals, Inc. Appoints David Chapman as Vice President, Marketing

    IRVING, Texas, March 24, 2017 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (NASDAQ:RETA) (“Reata” or the ...

    author_avatar
    NASDAQ Market News